Haemophilus influenzae: Difference between revisions
From IDWiki
Haemophilus influenzae
(Created page with "==Background== ===Microbiology=== * Species of Stain::Gram-negative Shape::bacillus within the genus Genus::Haemophilus * Deficient heme biosynthetic pathway leading to X-factor-dependent growth on media * The group includes ''Haemophilus influenzae'', Haemophilus aegyptius, and Haemophilus haemolyticus {{DISPLAYTITLE:''Haemophilus influenzae''}} [[Category::Gram-negative bacilli]]") |
(added duration) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
* Species of [[Stain::Gram-negative]] [[Shape::bacillus]] within the genus [[Genus::Haemophilus]] |
* Species of [[Stain::Gram-negative]] [[Shape::bacillus]] within the genus [[Genus::Haemophilus]] |
||
* Deficient heme biosynthetic pathway leading to X-factor-dependent growth on media |
* Deficient heme biosynthetic pathway leading to X-factor-dependent growth on media |
||
+ | * Fastidious growth with standard media |
||
+ | * May be encapsulated; non-encapsulated strains are referred to as "nontypeable" |
||
* The group includes ''Haemophilus influenzae'', [[Haemophilus aegyptius]], and [[Haemophilus haemolyticus]] |
* The group includes ''Haemophilus influenzae'', [[Haemophilus aegyptius]], and [[Haemophilus haemolyticus]] |
||
{{DISPLAYTITLE:''Haemophilus influenzae''}} |
{{DISPLAYTITLE:''Haemophilus influenzae''}} |
||
+ | {| class="wikitable" |
||
⚫ | |||
+ | ! rowspan="2" |Test |
||
+ | ! colspan="8" |Biotype |
||
+ | |- |
||
+ | !I |
||
+ | !II |
||
+ | !III |
||
+ | !IV |
||
+ | !V |
||
+ | !VI |
||
+ | !VII |
||
+ | !VIII |
||
+ | |- |
||
+ | |Indole |
||
+ | | + |
||
+ | | + |
||
+ | |– |
||
+ | |– |
||
+ | | + |
||
+ | |– |
||
+ | | + |
||
+ | | + |
||
+ | |- |
||
+ | |Urease |
||
+ | | + |
||
+ | | + |
||
+ | | + |
||
+ | | + |
||
+ | |– |
||
+ | |– |
||
+ | |– |
||
+ | |– |
||
+ | |- |
||
+ | |ODC |
||
+ | | + |
||
+ | |– |
||
+ | |– |
||
+ | | + |
||
+ | | + |
||
+ | | + |
||
+ | |– |
||
+ | |– |
||
+ | |} |
||
+ | |||
+ | == Clinical Manifestations == |
||
+ | |||
+ | * [[Community-acquired pneumonia]], particularly in children, [[meningitis]], [[bacteremia]], mainly type b strains |
||
+ | * [[Community-acquired pneumonia]], [[acute otitis media]], [[acute sinusitis]], [[acute exacerbation of COPD]], mainly untypeable strains |
||
+ | |||
+ | == Management == |
||
+ | |||
+ | * For beta-lactamase-negative strains, [[ampicillin]] is recommended |
||
+ | * For beta-lactamase-positive strains, [[ceftriaxone]] or [[cefepime]] |
||
+ | * Alternatives include [[chloramphenicol]], [[ertapenem]], [[meropenem]] |
||
+ | * Possibly also a [[Fluoroquinolones|fluoroquinolone]], [[azithromycin]], [[clarithromycin]], [[doxycycline]], [[amoxicillin-clavulanic acid]] |
||
+ | * Duration depends on syndrome being treated: |
||
+ | ** Uncomplicated [[Bacterial meningitis|meningitis]]: 10 days |
||
+ | ** [[Community-acquired pneumonia|Pneumonia]]: at least 5 days, with clinical improvement |
||
+ | ** [[Septic arthritis]]: 10 to 14 days |
||
+ | ** [[Pericarditis]]: 3 to 6 weeks |
||
+ | ** [[Empyema]]: 3 to 6 weeks |
||
+ | ** [[Osteomyelitis]]: 3 to 6 weeks |
||
+ | |||
+ | == Further Reading == |
||
+ | |||
+ | * Antimicrobial Resistance in ''Haemophilus influenzae''. ''Clin Microbiol Rev''. 2007. doi: [https://doi.org/10.1128/CMR.00040-06 10.1128/CMR.00040-06] |
||
+ | |||
⚫ |
Latest revision as of 13:25, 12 January 2024
Background
Microbiology
- Species of Gram-negative bacillus within the genus Haemophilus
- Deficient heme biosynthetic pathway leading to X-factor-dependent growth on media
- Fastidious growth with standard media
- May be encapsulated; non-encapsulated strains are referred to as "nontypeable"
- The group includes Haemophilus influenzae, Haemophilus aegyptius, and Haemophilus haemolyticus
Test | Biotype | |||||||
---|---|---|---|---|---|---|---|---|
I | II | III | IV | V | VI | VII | VIII | |
Indole | + | + | – | – | + | – | + | + |
Urease | + | + | + | + | – | – | – | – |
ODC | + | – | – | + | + | + | – | – |
Clinical Manifestations
- Community-acquired pneumonia, particularly in children, meningitis, bacteremia, mainly type b strains
- Community-acquired pneumonia, acute otitis media, acute sinusitis, acute exacerbation of COPD, mainly untypeable strains
Management
- For beta-lactamase-negative strains, ampicillin is recommended
- For beta-lactamase-positive strains, ceftriaxone or cefepime
- Alternatives include chloramphenicol, ertapenem, meropenem
- Possibly also a fluoroquinolone, azithromycin, clarithromycin, doxycycline, amoxicillin-clavulanic acid
- Duration depends on syndrome being treated:
- Uncomplicated meningitis: 10 days
- Pneumonia: at least 5 days, with clinical improvement
- Septic arthritis: 10 to 14 days
- Pericarditis: 3 to 6 weeks
- Empyema: 3 to 6 weeks
- Osteomyelitis: 3 to 6 weeks
Further Reading
- Antimicrobial Resistance in Haemophilus influenzae. Clin Microbiol Rev. 2007. doi: 10.1128/CMR.00040-06